Sign in / Join Now
ETFs & Funds
: blog by Dr. Preti of NBS re: acquisition of CSC and how it compliments NBS.
Add a reply...
Latest StockTalks »
people get CLBS breaking news and analysis by email alert.
Get email alerts on CLBS »
Caladrius Biosciences, Inc.
Get latest price
From other sites
Caladrius Biosciences Subsidiary, PCT, Earns FACT Re-Accreditation For Its Cell Therapy Development And Manufacturing Facilities
at TheStreet (Nov 22, 2016)
Caladrius Biosciences Reports 2016 Third Quarter Financial Results
at TheStreet (Nov 7, 2016)
Caladrius Biosciences To Host 2016 Third Quarter Financial Results Conference Call On November 7 At 5:00 Pm Eastern Time
at TheStreet (Nov 2, 2016)
Caladrius Biosciences Begins Enrollment Of Second Cohort Of Phase 2 Trial Of CLBS03 As A Treatment For Type 1 Diabetes Following Favorable Safety Data From First Cohort
at TheStreet (Oct 31, 2016)
Caladrius Biosciences To Present At Upcoming November Conferences
at TheStreet (Oct 27, 2016)